Will be interesting to see how this compares to Elite's unique situation being on OTC. My guess is that this study was for publicly held companies on a large exchange. I'm of frame of mind that there is much value waiting to be unlocked in an acquisition that is not currently baked into the price, more than just a 20-30% premium from current share price.